Page 2 - Biopharm Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurobindo Pharma subsidiary bags USFDA nod for Amphotericin B Liposome for Injection

This is a partnership product from TTY Biopharm Company Limited and will be manufactured at their Taiwan facility and marketed by Eugia Pharma.

South africaAndhra pradeshUnited kingdomEugia pharmaAmbisome liposomeEugia pharma specialitiesBiopharm companyAstellas pharma us incAurobindo pharmaUs food drug administrationHealth canadaEugia pharma speciality groupAurobindo pharma limitedSpecialities limitedDrug administrationAmphotericinb liposome

Eugia Pharma receives USFDA Approval for Amphotericin B Liposome for Injection

Eugia Pharma Specialities Limited, has received a final approval from the US Food & Drug Administration for Amphotericin B Liposome for Injection, 50 mg.

Eugia pharmaAmbisome liposomeEugia pharma specialitiesBiopharm companyAstellas pharma us incUs food drug administrationAurobindo pharmaEugia pharma speciality groupAmphotericinb liposomePharma limitedEugia pharma specialities limitedDrug administrationSingle dose vialAstellas pharmaCompany limitedCryptococcal meningitis

PAION AG S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM IN PROCEDURAL SEDATION IN TAIWAN

EQS-News: PAION AG / Key word: Market Launch PAION AG’S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM IN PROCEDURAL SEDATION IN TAIWAN 14.11.2022 / 15:10.

United kingdomSouth koreaSara houThorben burbachJim phillipsBiopharm company limitedBiopharm companyDrug administrationFrankfurt stock exchangePrime standardTaiwan foodCompany limited

PAION AG S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM IN PROCEDURAL SEDATION IN TAIWAN

EQS-News: PAION AG / Key word(s): Market LaunchPAION AG’S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM IN PROCEDURAL SEDATION IN TAIWAN 14.11.2022 / 15:10 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION AG’S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMA.

United kingdomSouth koreaSara houThorben burbachJim phillipsBiopharm company limitedBiopharm companyDrug administrationFrankfurt stock exchangeDistribution servicesMarket launchPrime standardTaiwan foodCompany limitedCorporate newsRegulatory announcements

Asia Deal Watch: Hansoh, TiumBio Join Forces On Endometriosis Drug In Greater China

Asia Deal Watch: Hansoh, TiumBio Join Forces On Endometriosis Drug In Greater China
informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.

South africaSoult ukpyolsiSouth koreaHansoh pharmaBiopharm companyImmvira co ltdHong china resources pharmaceutical groupCr biopharma and immvira to coAlcon incTiumbio co ltdShionogi coLomb incDrug administrationEverest medicinesPoint therapeutics incElevation oncology inc